First-in-Human, Single- and Multiple-Ascending Dose and Food-Effect Study of BGB-23339 in Healthy Participants
Clinical trial NCT05093270 · COMPLETED
Trial details
- NCT number
- NCT05093270
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-15
- Primary completion
- 2022-09-15
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.